A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

813

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

November 30, 2007

Study Completion Date

February 29, 2008

Conditions

Rheumatoid Arthritis

Interventions

DRUG

AMG 108

50mg via SC (subcutaneous) injection every 4 weeks

DRUG

AMG 108

250mg via SC (subcutaneous) injection every 4 weeks

DRUG

AMG 108

125mg via SC (subcutaneous) injection every 4 weeks

DRUG

Placebo

Placebo via SC (subcutaneous) injection every 4 weeks